{
  "resourceType": "ValueSet",
  "status": "active",
  "name": "DrugTherapyOther",
  "id": "pharmacological-therapy-other",
  "title": "Drug Therapy Other",
  "description": "Pharmacological therapy in the context of Covid-19, relevant custom-defined codes",
  "version": "1.0.6",
  "url": "https://www.netzwerk-universitaetsmedizin.de/fhir/ValueSet/pharmacological-therapy-other",
  "experimental": false,
  "publisher": "Berlin Institute of Health at CharitÃ© (BIH)",
  "contact": [
    {
      "telecom": [
        {
          "system": "url",
          "value": "https://www.bihealth.org/en/research/core-facilities/interoperability/"
        }
      ]
    }
  ],
  "meta": {
    "profile": [
      "http://hl7.org/fhir/StructureDefinition/shareablevalueset"
    ]
  },
  "immutable": false,
  "compose": {
    "include": [
      {
        "system": "https://www.netzwerk-universitaetsmedizin.de/fhir/CodeSystem/ecrf-parameter-codes",
        "concept": [
          {
            "code": "antipyretic",
            "display": "Product containing antipyretic"
          },
          {
            "code": "camostat",
            "display": "Product containing camostat"
          },
          {
            "code": "favipiravir",
            "display": "Product containing favipiravir"
          },
          {
            "code": "convalescent-plasma",
            "display": "Convalescent plasma"
          },
          {
            "code": "steroids-gt",
            "display": "Steroids (> 0.5 mg/kg prednisone equivalents)"
          },
          {
            "code": "steroids-lt",
            "display": "Steroids (<= 0.5 mg/kg prednisone equivalents)"
          }
        ]
      }
    ]
  }
}
